The invention relates to the field of medicine, and more particularly to emergency medical assistance. A respiratory intervention is performed on a patient with an artificial gas-air mixture having an increased content of argon of at least 30 vol %, enabling this artificial gas-air mixture to be effective continuously throughout the procedure. Furthermore, the respiratory gaseous medium has an increased content of oxygen with xenon being added and has the following composition: 1-10 vol % of xenon; 30-35 vol % of argon; 60-65 vol % of oxygen. The intervention on the patient with the artificial gas-air mixture of the composition mentioned is performed for 20-40 minutes or more, until specialized medical assistance is given. The method makes it possible to increase the effectiveness, safety and rapidity of relieving acute cerebral and cardiac ischemia, and to reduce the risk of developing an acute cerebral stroke or myocardial infarction.

The invention relates to the field of medicine, and more particularly to emergency medical assistance. A respiratory intervention is performed on a patient with an artificial gas-air mixture having an increased content of argon of at least 30 vol %, enabling this artificial gas-air mixture to be effective continuously throughout the procedure. Furthermore, the respiratory gaseous medium has an increased content of oxygen with xenon being added and has the following composition: 1-10 vol % of xenon; 30-35 vol % of argon; 60-65 vol % of oxygen. The intervention on the patient with the artificial gas-air mixture of the composition mentioned is performed for 20-40 minutes or more, until specialized medical assistance is given. The method makes it possible to increase the effectiveness, safety and rapidity of relieving acute cerebral and cardiac ischemia, and to reduce the risk of developing an acute cerebral stroke or myocardial infarction.

An infectious aerosol capture mask (IACM) includes a face tent coupled to a suction tube adapter. The face tent includes a proximal opening configured to be disposed over the mouth and nose of a patient. The face tent further includes a distal opening with a smaller diameter than the proximal opening. A coupler is configured to secure the suction tube adapter to the distal opening of the face tent. The suction tube adapter includes a suction port configured to be coupled to a suction tube for active capture of infectious aerosol and left unconnected for passive capture of infectious aerosol. A viral filter is disposed between the suction port and the face tent to capture infectious aerosols expelled by the patient. The IACM further includes one or more one-way valves that are configured to permit airflow into the face tent.

An infectious aerosol capture mask (IACM) includes a face tent coupled to a suction tube adapter. The face tent includes a proximal opening configured to be disposed over the mouth and nose of a patient. The face tent further includes a distal opening with a smaller diameter than the proximal opening. A coupler is configured to secure the suction tube adapter to the distal opening of the face tent. The suction tube adapter includes a suction port configured to be coupled to a suction tube for active capture of infectious aerosol and left unconnected for passive capture of infectious aerosol. A viral filter is disposed between the suction port and the face tent to capture infectious aerosols expelled by the patient. The IACM further includes one or more one-way valves that are configured to permit airflow into the face tent.

An apparatus for treating a tissue site includes a dressing, an oxygen source, a valve, and a negative-pressure source. The dressing is configured to be sealed around the tissue site. The oxygen source is fluidly coupled to the dressing and configured to provide a low flow of oxygen. A first port of the valve is fluidly coupled to the dressing and the valve moves between a closed position preventing flow through the valve and an open position permitting flow through the valve. The negative-pressure source is fluidly coupled to a second port of the valve and provides negative pressure to the second port of the valve at a non-therapeutic level. The valve separates the negative-pressure source from the dressing and selectively opens when a positive pressure is applied on an upstream side of the valve.

An intravenous IV pressure assembly includes a body, an outlet port disposed on the body and a connector coupled to the outlet port, the connector being configured to couple with a fluid reservoir and the IV pressure assembly configured as a pressurized container. IV sets with an IV pressure assembly and methods of operating an IV pressure assembly are also provided.

A gas mask, for use with a gas filter or with a demand oxygen system, includes an elastic mask body, a connector and a counter-support. The elastic mask body is configured to be placed over the mouth and the nose of a user of the gas mask. The connector is attached to the elastic mask body and is configured to fix a gas filter or an end piece of a tube in a mount of the connector. The counter-support is attached to the elastic mask body and has a contact area for a support projection of the connector. The connector and the counter-support are arranged such that a force exerted on the connector in a direction of the user acts on the contact area of the counter-support at least partially via the support projection. The support projection is integrated at the connector by manufacturing in one piece.

A connection device and process connect a patient-side coupling unit to a source/sink of a gas including oxygen. The connection device includes a valve device with a first valve (40.1) and with a second valve (40.2). A source-side fluid guide unit establishes a fluid connection between the source or the sink and the valve device. A patient-side fluid guide unit establishes a fluid connection between the patient-side coupling unit and the valve device. The valves are connected in parallel and are arranged between the two fluid guide units. A gas flows from the source through the first and/or second valve to the patient-side coupling unit or through the first and/or second valves to the sink. A control pressure is set at each valve. As a result, the time course of the volume flow downstream of the valve device follows a predefined time course.

An apparatus for controlling the flow of oxygen to a patient comprises an outer housing extending between first and second ends having a passage therethrough. The housing composes a first portion extending from the first end towards the second end and a second portion extending from the second end towards the first end wherein the second portion is threadably rotatable relative to the first portion so as to longitudinally displaced relative to the first portion under rotation thereof so as to adjust at least a portion of the passage extending therethrough adjusting a flow capacity of the passage. The apparatus further comprises connectors at each of the first and second ends operable to connect to oxygen conduits to fluidically conned the oxygen conduits to the passage through the housing.

A delivery device for and a method of delivering gases to the nasal airway, in particular therapeutic gases and gases in combination with active substances, either as powders or liquids, for enhanced uptake of the active substances.